"We do not seek conflict with Iran or any other country," Trump tells reporters in the Oval Office.Politicsread more
Nineteen billionaires release a letter asking the 2020 presidential candidates to support a tax on America's richest families.Economyread more
Sen. Bernie Sanders announced a plan Monday to forgive the country's $1.6 trillion outstanding student loan tab, intensifying the higher education policy debate in the 2020...Personal Financeread more
Shopify debuts a new network to help it compete with Amazon.Marketsread more
Home Depot CEO Craig Menear said the company aims to minimize any impact that potential tariffs will have on customers by cutting costs elsewhere in the supply chain. The...Retailread more
Shares of Bristol-Myers Squibb plunged Monday after announcing that the target closing date for the proposed acquisition of Celgene has been pushed back and that the deal will...Biotech and Pharmaceuticalsread more
These are the stocks posting the largest moves midday.Market Insiderread more
She takes the helm after Kevin Tsujihara was ousted in March after an investigation into sexual misconduct allegations.Entertainmentread more
The Trump administration had argued the president has wide-ranging authority over national security matters.Politicsread more
Gold surged to its highest level in nearly six years on Monday as the prospects of lower Federal Reserve rates and lingering geopolitical tensions between the U.S. and Iran...Marketsread more
Cashin believes the Fed could slash interest rates by an aggressive 0.5% at its next policymaking meeting at the end of July.The Fedread more
The SEC was investigating whether the drugstore chain's former chief executive and former chief financial officer failed to provide adequate warning about the risks associated with Walgreens' planned merger with Alliance Boots.
The SEC said former CEO Greg Wasson and then-CFO Wade Miquelon acted "negligently" when giving financial forecasts in June, October and December 2013 and March 2014 during earnings calls. Wasson and Miquelon were ordered to pay a $160,000 fine.
In settling, Walgreens and the executives neither admitted nor denied the allegations.
When Walgreens announced a two-step merger with Alliance Boots in June 2012, it projected the new company would generate $9 billion to $9.5 billion in combined adjusted operating income in the 2016 fiscal year. However, the SEC alleged that after completion of the first step of the merger, Walgreens' internal forecasts showed the company was at a "significantly" greater risk of missing those estimates.
Yet the two executives publicly reaffirmed the forecasts, the SEC alleged.
By November 2013, Walgreens had realized that an unanticipated increase in price of generic drugs would put further pressure on Walgreens' "already lagging" pharmacy business, the SEC said. The company lowered its fiscal 2016 forecast on Dec. 13. Since management was aware of the risk prior to December 2013, Walgreens' disclosures "failed to adequately disclose the increase in the risk," the agency said.
Then in 2014, Walgreens decided its 2016 operating income goal was "no longer reasonably attainable." It withdrew those goals on its June 24 earnings call and told investors it would soon provide a new set of goals.
On Aug. 6, Walgreens gave a new earnings per share estimate that translated to an adjusted operating income of $7.2 billion for fiscal year 2016, a 20 percent decline from its initial estimate. Shares fell 14.3 percent when Walgreens announced the new financial targets, according to the SEC.
"Over multiple reporting periods, senior Walgreens executives misled investors about the company's public financial goal," Stephanie Avakian, co-director of the SEC's Division of Enforcement, said in a statement. "The penalty assessed against Walgreens is intended to punish and deter such conduct, which deprived investors of information necessary to make fully informed investment decisions."
Walgreens in 2012 took a 45 percent stake in Alliance Boots for $6.7 billion with the option to later buy the remaining 55 percent. It closed the complete transaction at the end of 2014.
Wasson started as Walgreens' CEO in 2009 and left in 2015 when the merger with Alliance Boots closed and current CEO Stefano Pessina took the helm of the combined company. Miquelon served as Walgreens' CFO from 2008 and departed in August 2014.